Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCS-01 for Inflammation and Pain Following Cataract Surgery
NCT06128369Phase 3Terminated
- Sponsor
- Oculis
- Start
- Dec 2023
- Primary completion
- May 2024
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in endophthalmitis, Eye pain, sponsored by Oculis. Started Dec 2023; status: terminated.
02
Drugs
dexamethasone
03
Conditions
endophthalmitisEye pain
Beyond the preview
Go deeper on NCT06128369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06128369.